Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
571190-30-2
Purity
95%
Palbociclib is an endocrine-based chemotherapeutic agent used to treat HER2-negative and HR-positive advanced or metastatic breast cancer.
Properties
Name
Palbociclib
Smiles
CC(=O)C1=C(C)C=2C=NC(NC=3C=CC(=CN3)N4CCNCC4)=NC2N(C5CCCC5)C1=O
Targets
Please log in to see this information
Sold for research purposes under agreement from Pfizer Inc.
SDS
PBC | PD 0332991 | PD 332991 | PD-332991 | ibrance | palbociclib
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$64
45 mg
$21
50 mg
$22
75 mg
$29
100 mg
$74
Quantity
1
Total amount
$ 19
PBC | PD 0332991 | PD 332991 | PD-332991 | ibrance | palbociclib
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.